Error (ZVZZT) had the highest return in Q1 2024 by a US stock, returning 1,820%.

ASSET	QUARTER	% RETURN
error (ZVZZT)	Q1 2024	1,820.04%
LENZ Therapeutics (LENZ)	Q1 2024	1,175.05%
Binah Capital Group, Inc Warrants (BCGWW)	Q1 2024	858.26%
Elevation Oncology (ELEV)	Q1 2024	850%
Rail Vision Ltd Warrant (RVSNW)	Q1 2024	719.67%
Maris-Tech Ltd Warrants (MTEKW)	Q1 2024	699.5%
SoundHound AI (SOUNW)	Q1 2024	642.42%
Swvl (SWVL)	Q1 2024	640.63%
bioAffinity Technologies Inc Warrant (BIAFW)	Q1 2024	595.82%
Codere Online Luxembourg SA Warrants (CDROW)	Q1 2024	576.24%
Biofrontera Inc Warrants (BFRIW)	Q1 2024	576%
SK Growth Opportunities (SKGRW)	Q1 2024	571.43%
SRAX (SRAX)	Q1 2024	564.34%
Airship AI (AISPW)	Q1 2024	555.8%
Corbus Pharmaceuticals (CRBP)	Q1 2024	552.91%
Skye Bioscience, Inc Common Stock (SKYE)	Q1 2024	506.2%
Shineco (SISI)	Q1 2024	501.18%
Nexalin Technology (NXLIW)	Q1 2024	488.73%
Root (ROOT)	Q1 2024	486.18%
Ocean Biomedical (OCEA)	Q1 2024	484.1%
enGene Holdings Inc Warrants (ENGNW)	Q1 2024	478.55%
Zivo Bioscience (ZIVO)	Q1 2024	474.07%
NeuroSense Therapeutics Ltd Warrant (NRSNW)	Q1 2024	460%
GeneDx (WGSWW)	Q1 2024	450%
Fitell Corporation Ordinary Shares (FTEL)	Q1 2024	420.39%